A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State.

Publication Year: 2015

DOI:
10.1097/MJT.0000000000000247

PMCID:
PMC4585485

PMID:
25853236

Journal Information

Full Title: Am J Ther

Abbreviation: Am J Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"All authors were employees of the study sponsor at the time the study was conducted. Actavis is the US marketer of nebivolol.: The authors have no other conflicts of interest to declare."

Evidence found in paper:

"Editorial support (data checking, development of figures and tables, incorporation of authors' comments, wording suggestions) was provided by Lynn M. Anderson, Mark Blade, Vojislav Pejović, and Leah Richmond of Prescott Medical Communications Group, Chicago, IL, a contractor of the study sponsor. The authors would like to acknowledge the bioanalytical scientists at Forest Research Institute (Farmingdale, NY), Keystone Bioanalytical Inc., and Tandem Labs for their support on the bioanalysis of the study samples. The study was supported by the Forest Research Institute."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025